← Back to Search

Stem Cell Therapy

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Phase 2
Recruiting
Research Sponsored by Throne Biotechnologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment called Stem Cell Educator therapy for people with alopecia areata, a condition that causes hair loss. The treatment uses the patient's own immune cells exposed to stem cells to help reset the immune system. It targets patients who haven't had success with other treatments. Stem Cell Educator therapy involves circulating a patient's blood through a system that allows immune cells to interact with stem cells, aiming to reset the immune system.

Eligible Conditions
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The percentage change in scalp hair growth.
Secondary study objectives
Efficacy of modulation of autoimmune-related memory T-cell markers
Feasibility of SCE therapy
Preliminary efficacy of SCE therapy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Minoxidil therapyExperimental Treatment1 Intervention
Control subjects will receive treatment with topical 5% minoxidil
Group II: Hair regrowth by SCEExperimental Treatment1 Intervention
AA subjects will receive Stem Cell Educator therapy. Hair regrowth will be evaluated during six-month follow-up studies.

Find a Location

Who is running the clinical trial?

Throne Biotechnologies Inc.Lead Sponsor
6 Previous Clinical Trials
320 Total Patients Enrolled
1 Trials studying Alopecia Areata
30 Patients Enrolled for Alopecia Areata
Hackensack Meridian HealthOTHER
135 Previous Clinical Trials
30,302 Total Patients Enrolled
Yale UniversityOTHER
1,927 Previous Clinical Trials
3,031,712 Total Patients Enrolled
5 Trials studying Alopecia Areata
59 Patients Enrolled for Alopecia Areata
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top